. Author manuscript; available in PMC: 2022 Apr 15.

Published in final edited form as: J Comp Neurol. 2020 Sep 10;529(6):1121–1134. doi: 10.1002/cne.25011

TABLE 1.

Commercially available mouse lines with tamoxifen-inducible Cre in vascular mural cells

Mouse line	Promoter, approach	Age of induction	Reported phenotype repNG2+/NG2+repNG2+/rep	Background CreERT2-Reporter, No Tam	Reference
B6.Cg-Tg(Pdgfrβ-cre/ERT2)6096Rha/J JAX 029684 RRID:IMSR_JAX:029684	Pdgfrβ, tamoxife n ip	P6	100% / 100%	not available	(Eilken et al., 2017)
B6.Cg-Pdgfrβtm1.1 (cre/ERT2)Csln/J JAX 030201 RRID:IMSR_JAX:030201	Pdgfrβ, tamoxife n ip	P1-P42	84% / few percent of glial cells	not available	(Cuervo et al., 2017)
B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J JAX 008538 RRID:IMSR_JAX:008538	NG2 BAC 4-OHT	P2-P60	45 – 50% / 90% < 1% neurons	none	(Zhu et al., 2011)
B6.Cg-Gt(ROSA) 26Sortm14(CAG-tdTomato)Hze/J JAX 007914 RRID:IMSR_JAX:007914	CAG	reporter line	none	none	(Madisen et al., 2010)
B6;129S-Gt(ROSA)26Sortm39(CAG-hop/EYFP)Hze/J JAX 014539 RRID:IMSR_JAX:014539	CAG	reporter line / inactive Halorhodopsin	none	none	(Madisen et al., 2012)